Jerome Zacks is a Cardiology physician affiliated with Icahn School of Medicine at Mount Sinai. OpenAlex indexes 22 publications with 908 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1120 Park Ave
New York, NY 101281242
Telephone
212-289-8400Registry record last updated 4 Oct 2010.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- TerSera Therapeutics LLCProgram year20221 payment
- Abbott LaboratoriesProgram year20221 payment
- Astellas Pharma US IncProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
77.1%Statin26.5%Rosuvastatin Calcium73%Atorvastatin Calcium27%Part D<11 patientsBeta blocker20.2%Metoprolol Succinate100%Part D≥26 patients+ 4 more classes in this area
Metabolism & gastrointestinal
9.9%Biguanide (metformin)9.9%Metformin Hcl100%Part D<11 patientsHormonal (systemic)
7.2%l-Thyroxine7.2%Levothyroxine Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Efficacy and safety of evolocumab in statin-treated patients with cardiovascular risk factors: a systematic review and meta-analysis
Expert Opinion on Biological Therapy
2025 - Consensus Guideline for the Management of Peritoneal Metastases from Neuroendocrine Neoplasms
Annals of Surgical Oncology
2025 - THE LONG TERM EFFECT OF EVOLOCUMAB IN PATIENTS TAKING STATIN WITH KNOWN CARDIOVASCULAR RISK FACTORS
Journal of the American College of Cardiology
2025 - CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND HEART FAILURE RELATED MORTALITY IN THE UNITED STATES: TEMPORAL TRENDS FROM 1999 TO 2020
Journal of the American College of Cardiology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Gregg Stone, MD
Icahn School of Medicine at Mount Sinai
Jonathan Halperin, MD
Icahn School of Medicine at Mount Sinai
Donna Mancini, MD
Icahn School of Medicine at Mount Sinai
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”